Waldemar A Turski Selected Research

Kynurenic Acid (Kynurenate)

3/2022	Content of tryptophan and kynurenines in serum and milk of dairy cows with mastitis caused by Streptococcus spp.
1/2022	Evidence against involvement of kynurenate branch of kynurenine pathway in pathophysiology of Fuchs' dystrophy and keratoconus.
1/2021	Tryptophan Pathway Abnormalities in a Murine Model of Hereditary Glaucoma.
4/2020	Kynurenic acid and cancer: facts and controversies.
1/2019	Influence of Cyclooxygenase-2 Inhibitors on Kynurenic Acid Production in Rat Brain in Vitro.
1/2019	Kynurenic acid as the neglected ingredient of commercial baby formulas.
12/2018	Tryptophan, kynurenine, kynurenic acid concentrations and indoleamine 2,3-dioxygenase activity in serum and milk of dairy cows with subclinical mastitis caused by coagulase-negative staphylococci.
1/2017	Kynurenic Acid and Neuroprotective Activity of the Ketogenic Diet in the Eye.
6/2015	Quinaldic acid inhibits proliferation of colon cancer ht-29 cells in vitro: effects on signaling pathways.
5/2015	Serum tryptophan and its metabolites in female dogs undergoing ovariohysterectomy as treatment of pyometra or as elective spay surgery.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Waldemar A Turski Research Topics

Disease

14	Seizures (Absence Seizure) 01/2020 - 04/2003
7	Neoplasms (Cancer) 04/2020 - 01/2010
6	Colonic Neoplasms (Colon Cancer) 04/2019 - 07/2011
6	Status Epilepticus (Complex Partial Status Epilepticus) 06/2014 - 03/2007
4	Epilepsy (Aura) 04/2016 - 12/2004
3	Cataract (Cataracts) 01/2022 - 01/2007
3	Carcinogenesis 01/2021 - 10/2014
2	Mastitis 03/2022 - 12/2018
2	Glaucoma 01/2021 - 01/2017
2	Infections 01/2020 - 05/2015
2	Melanoma (Melanoma, Malignant) 01/2017 - 09/2013
2	Glioblastoma (Glioblastoma Multiforme) 10/2014 - 02/2014
2	Kidney Neoplasms (Kidney Cancer) 10/2014 - 10/2012
2	Acute Liver Failure (Fulminant Hepatic Failure) 06/2014 - 02/2004
2	Hepatic Encephalopathy 06/2014 - 02/2004
2	Glioma (Gliomas) 02/2014 - 06/2002
2	Ocular Hypertension (Glaucoma, Suspect) 01/2011 - 03/2004
2	Poisoning 03/2007 - 04/2003
1	Fuchs' Endothelial Dystrophy 01/2022
1	Keratoconus 01/2022
1	Early-Onset Glaucoma 01/2021
1	Absence Epilepsy (Childhood Absence Epilepsy) 04/2020
1	COVID-19 01/2020
1	Weight Gain 01/2019
1	Corneal Diseases (Corneal Disease) 01/2019
1	Central Nervous System Diseases (CNS Diseases) 01/2019
1	Eye Diseases (Eye Disease) 01/2017
1	Anti-N-Methyl-D-Aspartate Receptor Encephalitis 12/2016
1	Encephalitis (Encephalitis, Rasmussen) 12/2016
1	Pyometra 05/2015
1	Renal Cell Carcinoma (Grawitz Tumor) 10/2012
1	Carcinoma (Carcinomatosis) 07/2011
1	Adenoma (Adenomas) 07/2011
1	Hallucinations (Hallucination) 01/2011
1	Brain Edema (Cerebral Edema) 01/2011
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2010

Drug/Important Bio-Agent (IBA)

25	Kynurenic Acid (Kynurenate)IBA 03/2022 - 06/2002
10	KynurenineIBA 03/2022 - 05/2003
9	Tryptophan (L-Tryptophan)FDA Link 03/2022 - 01/2007
8	Anticonvulsants (Antiepileptic Drugs)IBA 04/2016 - 05/2006
8	N-Methylaspartate (NMDA)IBA 04/2016 - 04/2003
5	Pentylenetetrazole (Metrazol)IBA 01/2020 - 12/2004
5	Pilocarpine (Ocusert)FDA LinkGeneric 04/2016 - 03/2007
4	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 03/2022 - 05/2015
4	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 12/2016 - 05/2003
4	Dizocilpine Maleate (Dizocilpine)IBA 06/2014 - 04/2003
4	Transaminases (Aminotransferases)IBA 09/2013 - 05/2003
3	Pharmaceutical PreparationsIBA 04/2020 - 07/2009
3	Proteins (Proteins, Gene)FDA Link 04/2019 - 01/2007
3	Retinaldehyde (Retinal)IBA 01/2017 - 03/2004
3	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 04/2016 - 06/2007
3	imidazole mustard (BIC)IBA 04/2016 - 06/2007
3	Kainic Acid (Kainate)IBA 04/2016 - 06/2007
3	BicucullineIBA 04/2016 - 06/2007
3	Orphenadrine (Disipal)FDA LinkGeneric 06/2014 - 07/2009
3	Glutamic Acid (Glutamate)FDA Link 06/2014 - 09/2004
2	EnzymesIBA 01/2021 - 05/2003
2	Biological ProductsIBA 04/2020 - 07/2011
2	quinaldic acidIBA 04/2019 - 06/2015
2	AntibodiesIBA 01/2017 - 09/2013
2	nicotinic acid benzylamideIBA 04/2016 - 05/2006
2	Excitatory Amino Acid AntagonistsIBA 02/2014 - 05/2003
2	Bromodeoxyuridine (BrdU)IBA 02/2014 - 01/2012
2	Topiramate (Topamax)FDA LinkGeneric 02/2010 - 07/2009
2	Lamotrigine (Lamictal)FDA LinkGeneric 07/2009 - 07/2006
2	Phenytoin (Dilantin)FDA LinkGeneric 07/2009 - 07/2006
2	Phenobarbital (Luminal)FDA Link 07/2009 - 07/2006
2	Carbamazepine (Tegretol)FDA LinkGeneric 07/2009 - 07/2006
2	Atropine FDA LinkGeneric 03/2007 - 04/2003
2	AcetylcholinesteraseIBA 03/2007 - 04/2003
2	DichlorvosIBA 03/2007 - 04/2003
2	Cholinergic Agents (Cholinergics)IBA 03/2007 - 04/2003
1	Neuroprotective AgentsIBA 01/2022
1	Crystallins (Crystallin)IBA 01/2022
1	Free RadicalsIBA 01/2022
1	palmatineIBA 01/2020
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2020
1	Tocopherols (Tocopherol)IBA 01/2020
1	Calcitriol (Calcijex)FDA LinkGeneric 01/2020
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2019
1	CoagulaseIBA 12/2018
1	Niacin (Nicotinic Acid)FDA LinkGeneric 04/2016
1	AcidsIBA 04/2016
1	Mitogen-Activated Protein KinasesIBA 10/2014
1	CateninsIBA 10/2014
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 10/2014
1	GYKI 52466IBA 02/2014
1	Coloring Agents (Dyes)IBA 09/2013
1	DNA (Deoxyribonucleic Acid)IBA 10/2012
1	Small Interfering RNA (siRNA)IBA 01/2012
1	Cyclin-Dependent Kinase Inhibitor p21IBA 01/2012
1	N 30IBA 07/2011
1	Therapeutic UsesIBA 01/2011
1	Nefopam (Ajan)IBA 01/2011

Therapy/Procedure

2	Therapeutics 04/2020 - 01/2020
2	Lenses 09/2013 - 01/2007
1	Ketogenic Diet 01/2017
1	Plasmapheresis 12/2016
1	Drug Therapy (Chemotherapy) 10/2014
1	Chemoprevention 01/2012